cidofovir anhydrous has been researched along with 2019 Novel Coronavirus Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aldhafeeri, AA; Alharbi, AS; Allahyani, M; Almehmadi, M; Alotaibi, AN; Alotaibi, SS; Alsaiari, AA; Alshammari, MK; Alsubaihi, LI; Hussain, KH; Imran, M; Kamal, M | 1 |
| Anderson, TK; Chien, M; Jockusch, S; Ju, J; Kirchdoerfer, RN; Kumar, S; Li, X; Russo, JJ; Tao, C | 1 |
1 review(s) available for cidofovir anhydrous and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
A Glance at the Development and Patent Literature of Tecovirimat: The First-in-Class Therapy for Emerging Monkeypox Outbreak.
Topics: Animals; Antiviral Agents; Cidofovir; COVID-19; Disease Outbreaks; Immunoglobulin A, Secretory; Monkeypox virus; Mpox (monkeypox); Orthopoxvirus; Rabbits; Smallpox; United States; Variola virus | 2022 |
1 other study(ies) available for cidofovir anhydrous and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
A library of nucleotide analogues terminate RNA synthesis catalyzed by polymerases of coronaviruses that cause SARS and COVID-19.
Topics: Antiviral Agents; Betacoronavirus; Cidofovir; Coronavirus Infections; COVID-19; Dideoxynucleosides; Ganciclovir; Guanine; Nucleotides; Pandemics; Pneumonia, Viral; Prodrugs; RNA-Dependent RNA Polymerase; RNA, Viral; SARS-CoV-2; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus; Stavudine; Valganciclovir | 2020 |